Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer

Completed · Not applicable

Conditions studied: Pancreatic Cancer

In brief

The aim of this study is to evaluate if the early change of needle during EUS-FNA for suspected pancreatic cancer allows an earlier preliminary cytological diagnosis of neoplasia.

Key facts

Study ID

NCT00548626

Run by

University of Chicago

People needed

47

Starts

2007-10-01

Expected to finish

2015-11-01

Last updated by the study team

2015-12-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Suspicion of pancreatic mass due to previous exam/s (CT, MR, ERCP, US, …) that requires EUS-FNA in order to complete diagnosis
• Age ≥ 18 y/o
• Formal informed consent
• No previous chemotherapy or radiotherapy
• No previous pancreatic surgery

You may not qualify if…

• Any patient unable to understand the procedure, nature of the current study, or sign a consent form.

Where it is running

• University of Chicago Medical Center — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.